{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "complex_factors": [
        "Leverage",
        "Inverse Exposure",
        "Synthetic Replication via Swaps",
        "Daily Reset and Compounding Effects",
        "Counterparty Risk",
        "Collateralised Debt Security Structure"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree FTSE 100 3x Daily Short is a fully collateralised, UCITS eligible Exchange Traded Product (ETP) that provides leveraged short exposure (-3x) to the FTSE 100 index. The product uses a fully collateralised swap-based synthetic replication method to achieve its investment objective, explicitly referencing swap agreements and collateral held with The Bank of New York Mellon. The product is structured as a debt security, not as an ETF in the traditional sense, and is not UCITS compliant despite being UCITS eligible. The leverage factor is -3x with daily reset, causing compounding effects that make the product's return non-linear and complex over periods longer than one day. The risk indicator is at the highest level (7/7), indicating very high risk. The product documentation repeatedly warns that it is not simple, requires specific knowledge, and is intended for informed or sophisticated investors. The product carries significant counterparty risk due to reliance on swap counterparties, with collateral management risks disclosed. The product is exposed to derivative instruments inherently as part of its strategy, not merely for risk management. The product also involves costs related to transaction and management fees, but no performance fees. The daily reset and compounding effects, combined with leverage and inverse exposure, add to the complexity. The product is not UCITS compliant, which is relevant for regulatory classification. The PRIIPs KID explicitly states the product is 'not simple and may be difficult to understand,' reinforcing the complexity classification. The monthly factsheet confirms the use of fully collateralised swaps and the synthetic nature of the exposure. Overall, the combination of synthetic replication, leverage, inverse exposure, swap usage, counterparty risk, and complex return profile leads to a clear classification as a complex financial instrument under MiFID II."
}